AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpure M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimpure M 2mg/500mg Tablet SR

DiaGlym-M 2mg/500mg extended-release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. DiaGlym-M should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled glucose levels; abrupt cessation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimpure M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimpure M 2mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimpure M 2mg/500mg Sustained-Release Tablets with food.

Common Side effects of Glimpure M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimpure M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpure M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Glimpure M 2mg/500mg Tablet SR works:

Glimpure M SR tablets (2mg/500mg) combine glimepiride and metformin, two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpure M 2mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimpure M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimpure M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimpure M 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimpure M 2mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimpure M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation with a low dose of Glimpure M 2mg/500mg SR tablets is typical; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Glimpure M 2mg/500mg Tablet SR :

Should you forget to take your Glimpure M 2mg/500mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpure M 2mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimpure M 2mg/500mg Tablet SR

Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, animals, and other individuals.
Glimpure M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate discontinuation of Glimpure M 2mg/500mg Tablet SR and prompt medical attention.
Glimespan SR tablets, containing 2mg Glimepiride and 500mg Metformin, manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when combined with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin simultaneously decreases hepatic glucose output and improves cellular insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glimpure M 2mg/500mg sustained-release tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis have also been reported. Prolonged administration may result in vitamin B12 deficiency.
Prolonged use of Glimpure M 2mg/500mg SR tablets can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Consequently, if left unaddressed, anemia and neurological complications may arise, manifesting as tingling or numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and balance disorders (ataxia). To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, has been proposed by some investigators.
Indeed, Glimpure M 2mg/500mg Extended-Release Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimpure M 2mg/500mg SR tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Concurrent use also elevates the likelihood of lactic acidosis.
Glimpure M 2mg/500mg Tabl...
163
MRP 199
18% off